Table 3.
Descriptions for the collected information in CBD2.
| Items | Description |
|---|---|
| ID | Biomarker ID in the database |
| Name | Name of (non) biomarker |
| Category | Biological type of biomarker (e.g., protein, DNA) |
| NCBI protein | Protein information in the National Center for Biotechnology Information (NCBI) |
| Description | Description of biomarker |
| Region | The region where this biomarker research from |
| Race | The sample race of this biomarker research |
| Number | Sample number included in this biomarker research |
| Gender (male/female) | Gender distribution of sample number: Male/female |
| Age | Ages of samples: Mean age (minimum–maximum) |
| Location | Cancer location |
| Stage | Cancer stage |
| Source | Sample source |
| Experiment | Experiment method for research |
| Statistics | Statistics result for a biomarker in research |
| Application | Biomarker application |
| Clinical use | Whether the biomarker has been used in clinical practice |
| Conclusion | Research conclusion for this biomarker |
| Reference | First author, published Journal, and year of research |
| PMID | PubMed ID of research |
| STRING name | Name of the protein in the STRING database (If available) |
| STRING PPI | Show the protein–protein interaction (PPI) network of this protein with Other proteins with top 10 confidence scores (If STRING name is available) |
| Know target | Whether the current biomarker is a documented target in DrugBank |
| Drugs | Drugs on the target that have been recorded in DrugBank (if any) |
| Addition | Note by us |